WAVE Life Sciences (NASDAQ: WVE) reported quarterly losses of $(0.34) per share which missed the analyst consensus estimate of $(0.31) by 9.68 percent. This is a 9.68 percent decrease over losses of $(0.31) per share from the same period last year. The company reported quarterly sales of $2.272 million which missed the analyst consensus estimate of $7.050 million by 67.77 percent. This is a 73.88 percent decrease over sales of $8.699 million the same period last year.